TG Therapeutics logo
TG Therapeutics TGTX
€ 22.19 -10.2%

Quartalsbericht 2024-Q2
hinzugefügt 09.08.2024

report update icon

TG Therapeutics Kennzahlen 2011-2024 | TGTX

Kennzahlen Jährlich TG Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

191.2 -10.3 -4.4 -19.9 -7.3 -1.9 -6.1 -2.9 -5.9 -8.7 -7.6 -2.6 -2.3

P/S

10.4 734.7 228.7 36626.0 8284.6 2149.8 4765.8 1512.6 2447.4 3183.7 1024.0 2512.9 -

EPS

0.1 -1.5 -2.6 -2.4 -2.0 -2.3 -1.9 -1.6 -1.4 -1.6 -0.8 -1.4 -0.4

EV (Enterprise Value)

2.5 B 2.08 B 1.37 B 5.12 B 1.27 B 344 M 700 M 224 M 330 M 436 M 124 M 37.9 M -1.53 M

EBITDA per Share

0.15 -1.42 -2.61 -2.37 -1.91 -2.31 -1.91 -1.61 -1.38 -1.64 -0.794 -1.97 -0.458

EV/EBITDA

-3.8 -18.5 -7.0 -1.6 -5.6 -2.6 -5.0 -7.7 -5.8 -1.3 3.3

PEG

-6.87 6.58 -0.39 -1.59 -0.49 0.09 0.32 0.18 -0.37 0.08 -0.18 0.01 0.03

P/B

15.1 34.9 6.5 10.7 32.6 13.6 10.8 6.4 3.7 6.1 3.9 3.1 0.2

P/CF

-77.1 -11.6 -5.2 -26.0 -9.5 -2.5 -7.7 -3.7 -8.3 -13.8 -14.4 -9.2 -22.5

ROE %

7.90 -338.53 -146.78 -53.79 -447.68 -721.76 -176.85 -218.17 -61.97 -69.64 -51.13 -116.22 -8.86

ROA %

3.84 -102.46 -91.70 -44.66 -106.05 -207.47 -121.66 -142.85 -55.47 -64.30 -42.56 -81.87 -5.36

ROCE %

12.86 -329.15 -145.38 -52.68 -215.18 -389.62 -170.99 -208.34 -61.37 -68.26 -48.26 -129.87 -6.22

Current Ratio

1.9 1.4 2.7 5.9 1.8 2.0 3.3 3.0 8.3 16.6 6.7 8.3 6.1

DSO

- - 37.9 - - 228.1 259.8 200.9 445.6 204.8 65.1 - -

DIO

514.3 - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

514.3 - 37.9 - - - - - - - - - -

Finanzkreislauf

514.3 - 37.9 - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich TG Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.05 -0.07 - 0.8 -0.34 -0.28 - -0.26 -0.3 -0.51 - -0.65 -0.59 -0.69 - -0.73 -0.47 -0.48 -0.44 -0.69 -0.42 -0.43 -0.68 -0.43 -0.59 -0.59 -0.46 -0.48 -0.45 -0.52 -0.48 -0.5 -0.33 -0.28 -0.37 -0.28 -0.38 -0.35 -0.48 -0.51 -0.36 -0.25 - -0.16 -0.29 -0.17 - -0.16 -0.16 -2.03 - -0.01 -0.15 -

EBITDA per Share

- -0.06 - - - -0.26 - -0.26 -0.29 -0.5 - -0.64 -0.59 -0.68 - -0.72 -0.45 -0.48 - -0.68 -0.41 -0.43 - -0.44 0.6 -0.59 - -0.48 -0.45 -0.52 - -0.51 -0.33 -0.29 - -0.29 -0.38 -0.36 - -0.51 -0.36 -0.25 - -0.17 -0.29 -0.17 - -0.17 -0.26 -3.43 - -0.01 -0.16 -

ROE %

135.48 13.91 -191.56 -227.20 -332.00 -245.70 -107.55 -135.04 -126.88 -115.97 -68.33 -85.11 -74.41 -64.10 -36.81 -139.28 -282.88 -366.48 -447.68 -569.28 -550.15 -640.02 -721.76 -543.74 -449.57 -308.24 -176.85 -196.79 -218.94 -220.95 -218.17 -169.51 -113.72 -86.23 -61.97 -68.10 -76.44 -74.57 -69.64 -57.55 -47.14 -48.61 -36.99 -63.26 -78.16 -78.92 -130.85 -131.14 -105.17 -90.90 - -0.30 -2.93 -

ROA %

67.67 44.40 -7.02 -23.46 -74.31 -68.85 -55.31 -76.21 -80.68 -80.89 -53.73 -67.66 -60.69 -52.83 -30.55 -54.83 -78.89 -92.65 -106.05 -146.19 -148.80 -179.37 -207.47 -174.75 -166.53 -142.86 -121.66 -133.19 -146.13 -146.04 -142.85 -115.15 -81.86 -67.91 -55.47 -61.62 -69.70 -68.45 -64.30 -52.11 -41.46 -41.33 -30.79 -41.95 -43.63 -38.53 -66.20 -66.38 -55.41 -48.60 - -0.18 -1.77 -

ROCE %

138.50 23.10 -175.62 -210.41 -314.87 -234.61 -104.22 -131.55 -124.08 -114.13 -67.59 -84.09 -73.27 -62.83 -35.97 -193.58 -334.68 -416.94 -339.49 -482.31 -467.52 -190.98 -131.30 -178.45 -82.78 -309.70 -130.87 -200.37 -222.71 -224.96 -153.18 -166.79 -110.91 -83.08 -44.83 -66.61 -74.77 -72.84 -46.19 -57.79 -47.63 -49.25 -37.42 -66.39 -83.75 -95.38 -205.26 -205.57 -176.92 -151.82 - -0.31 -3.09 -

Current Ratio

1.8 1.8 1.9 2.0 1.2 1.2 1.4 1.9 2.0 2.3 2.7 4.2 4.9 5.3 5.9 5.9 5.9 5.9 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 3.2 3.2 3.2 3.2 2.9 2.9 2.9 2.9 9.5 9.5 9.5 9.5 13.1 13.1 13.1 13.1 6.0 6.0 6.0 6.0 3.4 3.4 3.4 3.4 3.0 2.5 2.5 2.5

DSO

92.3 83.4 - 15.6 74.1 50.4 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

873.4 985.6 - 829.4 1371.7 1449.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

965.7 1069.1 - 845.0 1445.8 1499.6 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

965.7 1069.1 - 845.0 1445.8 1499.6 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung